Professor Cameron Turtle is the Clearbridge Chair in Cancer Immunotherapy at The University of Sydney and joined the Mater Research Advisory Board in 2023.
He completed his PhD in dendriticcell immunotherapy through Mater Research in 2005, under the supervision of Mater Research’s inaugural Director, Professor Derek Hart, for which he was awarded the Sister Regis Mary Dunne Medal.
He trained as a haematologist and has worked at the Fred Hutchinson Cancer Center, Seattle USA, leading clinical and laboratory research teams in the field of cellular immunotherapy.